Human Leukocyte Antigen Antibody-Incompatible Renal Transplantation: Excellent Medium-Term Outcomes With Negative Cytotoxic Crossmatch-Reference-Cited by-同舟云学术

Human Leukocyte Antigen Antibody-Incompatible Renal Transplantation: Excellent Medium-Term Outcomes With Negative Cytotoxic Crossmatch

Published:2011-10-27 Issue:8 Volume:92 Page:900-906
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Higgins Robert,Lowe David,Hathaway Mark,Williams Clare,Lam For T.,Kashi Habib,Tan Lam Chin,Imray Chris,Fletcher Simon,Chen Klaus,Krishnan Nithya,Hamer Rizwan,Daga Sunil,Edey Matthew,Zehnder Daniel,Briggs David

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference24 articles.

1. Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation.;Palmer;Lancet,1989

2. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.;Montgomery;Transplantation,2000

3. Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation.;Higgins;Lancet,1996

4. Consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols.;Montgomery;Transplantation,2004

5. UK registry of antibody incompatible transplantation 2001–2010.;Higgins;Transplantation,2010

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imlifidase: Is it the Magic Wand in Renal Transplantation?;Indian Journal of Nephrology;2024-04-29

2. Impact of Low-Level Donor-Specific Anti-HLA Antibody on Posttransplant Clinical Outcomes in Kidney Transplant Recipients;Annals of Laboratory Medicine;2023-02-24

3. Impact of Low-level Donor-specific Antibody Determined With a Positive Luminex and Negative Flow Cytometric Crossmatch on Kidney Transplantation Outcomes;Annals of Laboratory Medicine;2023-02-24

4. Defining the lower and upper limits of immunological risk of HLA antibody incompatible kidney transplantation: Current state of the art and limitations;Transplant Immunology;2023-02

5. The detrimental effect of donor-specific antibodies is irrespective of its level in highly-immunized living donor kidney transplant recipients: A case-control series;Frontiers in Immunology;2023-01-10